Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
In the time-to-event analysis, the rate of the first occurrence of death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke among patients with type ...
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 6,755
- Institution
- Novo Nordisk (Denmark)
External Links
Identifiers
- ORCID
- 0000-0001-5431-824X
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.